Physician profile
Daniel R Thull
NPI 1518168640
$3,578.38
in general payments reported to CMS, 2019-2025
38 companies · $417 in 2025
The $417 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $709 · 2022: $945 · 2023: $661 · 2024: $847 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,924.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,924.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $649.68 | 2022-2025 | Carto 3 |
| Nestle Healthcare Nutrition INC. | $409.16 | 2021-2023 | |
| Glaxosmithkline, LLC. | $262.92 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Aimmune Therapeutics, INC. | $254.47 | 2024-2025 | Zenpep |
| Lilly USA, LLC | $196.04 | 2021-2025 | Mounjaro, Zepbound |
| Janssen Pharmaceuticals, INC | $194.37 | 2021-2024 | Xarelto, Spravato |
| Novo Nordisk INC | $162.32 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Takeda Pharmaceuticals U.S.A., INC. | $128.85 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $127.79 | 2021-2025 | Farxiga, Breztri |
| Alafair Biosciences, INC. | $125.00 | 2022 | |
| Abbvie INC. | $113.15 | 2021-2023 | |
| Otsuka America Pharmaceutical, INC. | $100.85 | 2021-2023 | Rexulti |
| Phathom Pharmaceuticals, INC. | $100.16 | 2024 | Voquezna |
| Abbott Laboratories | $98.43 | 2021-2024 | Freestyle Libre 3 |
| Kowa Pharmaceuticals America, INC. | $74.11 | 2021-2022 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Thull listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.